News and Updates
We are attending Respiratory Drug Delivery Europe 2023!
Here at APT, we offer the future of advanced powder blending and formulation development with our patented isothermal dry particle coater (iDPC). Whether you are
Are you currently developing a high-dose respiratory product (intranasal or inhalation)?
Click below to access the second of our two papers from Drug Delivery to the Lungs (DDL) 2022 titled “Modulating the Fine Particle Fraction, Surface Area and
APT’s Innovation Spotlight Talk at DDL 2022
APT’s Development Director Dr. Jasdip Koner, delivered an innovation spotlight talk at the brilliant DDL 2022 conference. This was such a great experience from start
Isothermal Dry Particle Coating for Dry Powder Inhaler (DPI) Formulations by Design
We are delighted to be releasing the first of two papers titled “Isothermal Dry Particle Coating (iDPC) – Dry Powder Inhaler (DPI) Formulations by Design:
APT Launches New Website
APT proudly launches a new website, showcasing its innovative iDPC technology with applications in respiratory, oral, and biological formulations – the future of powder formulation
Aston University – APT Co-Sponsored PhD has Started!
APT’s first co-sponsored PhD project has now started at Aston University. The PhD will provide insight into how iDPC can formulate amino acids as adjuvants
Our First Placement Student Experience
APT’s first undergraduate placement has come to an end. Tahreem Javaid was a great asset to the company over the past year and has put
2 New Placement Students Join the Team
APT are delighted to welcome two new sandwich degree placement students to our team. Isobel Clark is joining from Aston University’s Biomedical Science course and
APT are excited to announce that the fundamental Patent covering the iDPC technology has been granted in the US and Japan in summer 2021 following
APT to Co-sponsor first PhD with Aston University
Congratulations to Professor Afzal Mohammed for the award of an MIBTP and BBSRC funded PhD looking at the Mechanistic evaluation of amino acids as adjuvants
Our Team has expanded!
The APT team has expanded! We are excited to announce that Amandip Gill has joined APT as a Formulation/Research Scientist and we have taken on
COVID-19 Update – We are back!
After a short shutdown due to the current Coronavirus pandemic APT are excited to be resuming R&D and lab work! Aston University is now on
APT-Hale™ – The solution to all your DPI needs!
Aston Particle Technologies is delighted to announce publishing of its first Trademark – APT-Hale™. APT-Hale™ is APT’s unique platform for manufacture of dry powder inhalers
*Update January 2020 APT’s first patent covering the iDPC technology has been granted in Europe. Review process is still underway in the USA, Japan and